Funding for this research was provided by:
Innovative Medical Research of the University of Münster Medical School (RO221907)
Deutsche Forschungsgemeinschaft (KFO342)
Received: 16 September 2020
Accepted: 28 September 2020
First Online: 14 October 2020
Compliance with ethical standards
: IO, KB, JS, PRT, MF, JK, SB, UG, GT, AG, HP, and PK declare no competing interests. AR holds shares of Novavax, Moderna, and Curevac. HV is Chief Science Officer of GlycoCheck BV, The Netherlands.
: Patients were enrolled upon after obtaining written informed consent from them or their legal representatives.
: The study was performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the General Medical Council Westfalen-Lippe and the WWU Münster, Germany (file number: amendments of 2016-073-f-S).